New @AmerGastroAssn guidance on #diet in inflammatory bowel disease
๐ฅMediterranean diet
โ EEN & CDED in CD
โ screen for malnutrition and vitamin deficiencies
โ collaborate with RD
โ breastfeeding is protective
#MedTwitter#GITwitter#IBD
https://t.co/aUOTueR2PV
Read the latest #GUTBlog on
"Early management of ASUC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response" via https://t.co/BYFrgc8V0Q
Paper: https://t.co/mlwLqMyv3m
@OUH_Research@OxfordBRC#IBD#ASUC
Highlights from this new talk and sequencing in #Crohns.
โถ๏ธ Risk:benefit considerations are dynamic & depend on the severity and the phase of management.
โถ๏ธ Treat-to-target should guide therapy choice.
โถ๏ธ progress in clinical immunology is helping with some choices.
#ECCO23
Pragmatic summary of drug sequencing in UC. #ECCO23. Evidence allows for individual decision making taking into account patient factors, drug factors, system factors and clinician factors.
Pragmatic summary of drug sequencing in UC. #ECCO23. Evidence allows for individual decision making taking into account patient factors, drug factors, system factors and clinician factors.
ECCO20: Reduced need for surgery and medical therapy after early ileocaecal resection for Crohnโs disease: Long-term follow-up of the LIR!C trial
https://t.co/WZryQCQiQx
DigestThis! is webcast series covering Hot topics in Gastroenterology... this release is a good one! Anorexia Nervosa with the inimitable Dr McKinlay. Watch here ๐
https://t.co/tCi9qiau5H
OP168 Dr Pineton deChambrun: prospective multicenter French GETAID study of use of ADA in Crohns pts with intra-abdom abscessโstart within 3 weeks of drainageโwk 24 success was high #UEGW2019
@MRegueiroMD Should add we screen (and vaccinate) all our newly diagnosed patients using ECCO checklist but often patients present more acutely and donโt have luxury of time